Product Details
Januvia
Sitagliptin Phosphate Monohydrate25 mg
Tablet
DIN/PIN/NPN
02388839
Manufacturer
Merck Frosst Canada Ltd.
Formulary Listing Date
2013-09-27
Unit Price
3.2787
Amount MOH Pays
0.8197
Coverage Status
General Benefit Chronic-Use Medication Insulin or Oral Hypoglycemic Product
ODB Formulary Therapeutic Classification
Therapeutic Note
Sitagliptin Phosphate Monohydrate 25 mg Tablet: Treatment of Type 2 diabetes in patients on maximally tolerated doses of metformin who have: . Inadequate glycemic control (defined as HbA1c greater than 0.07) and intolerance or contraindication to a sulfonylurea; OR . Inadequate glycemic control (HbA1c greater than 0.07) and on maximal doses of sulfonylurea and for whom insulin is not an option.
ATC Code
A10BH01
Interchangeable Products
| DIN/ PIN/ NPN | Brand name | Unit Price | Amount MOH pays |
|---|---|---|---|
| 02388839 | Januvia | 3.2787 | 0.8197 |
| 02508656 | Apo-Sitagliptin Malate | 0.8197 | 0.8197 |
| 02529866 | Auro-Sitagliptin | 0.8197 | 0.8197 |
| 02534134 | Jamp Sitagliptin | 0.8197 | 0.8197 |
| 02504049 | Sandoz Sitagliptin | 0.8197 | 0.8197 |
| 02531631 | Taro-Sitagliptin Fumarate | 0.8197 | 0.8197 |
| 02529033 | Sitagliptin | 0.8197 | 0.8197 |
| 02512475 | Ach-Sitagliptin | 0.8197 | 0.8197 |
| 02522705 | Teva-Sitagliptin Malate | 0.8197 | 0.8197 |